← Evidence map

ArticleBMC cancer2015

A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity.

Lily Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25881012